In ‘Evaluation of Local Tissue Reaction After the Application of a 3D Printed Novel Holdfast Device for Left Atrial Appendage Exclusion,’ researchers from Poland begin to experiment even further with 3D printed devices for assistance in cardiac procedures. Here, they experiment with the use of a new holdfast device meant ultimately to help eliminate chances of ischemic stroke. Employing the benefits of SLS 3D printing—with the capabilities to use versatile materials with even greater affordability—the researchers evaluated the results of their new device, implanting the devices in a group of 30 swine.
A finger-like extension of the left atrium, the left atrial appendage is a non-functional part of the left atrium. It happens to be a ‘prime cardiac site’ for thrombus formation, affecting patients with atrial fibrillation more commonly. And while treatment with antithrombotic treatment is widespread, here, the researchers investigate a more comprehensive approach in ‘obliterating the LAA.’ The use of holdfast devices, while effective, has been fraught with disadvantages, from issues with blood leakage to post-insertion adjustments, and lack of flexibility for modifications.
“Considering the advantages and disadvantages of the available LAA closure devices, we designed a novel holdfast device for LAA obliteration devoid of these shortcomings,” stated the researchers.
The study allowed the researchers to further test biocompatibility, along with observing post-implementation issues. The device was created in partnership with the Technical University of Gdańsk, Poland, made up of two tubes connected with an elastic bow.
“The concept of operation for the device was based on the idea that the tubes would press the LAA base, which would lead to its closure and occlude the connection between the LAA and left atrium,” stated the researchers. “Moreover, the intention was that the device could be freely positioned around the LAA and could be easily adjusted after implantation.”
Their goal was to create a low stiffness spring with a ‘highly degressive characteristic of the device.’ They were able to do this through their choice of material and through shifting the bow crossection axis, with the devices implanted into the two swine groups. Safety and biocompatibility were noted, along with biofunctionality.
There were no perioperative deaths, and LAA occlusions occurred in all the swine.
“The foreign body reaction of the LAA holdfast device made of polyamide powder was found to be at a statistically insignificant level and was lower when compared to the polyester graft. Our device fulfills the criteria of biocompatibility to the highest degree, which makes it a suitable material for manufacturing LAA holdfast devices,” concluded the researchers. “This study proves that our technology may be applied for quick, innovative and individualized production of medical implants.“
3D printing has made huge strides in the medical realm, and definitely within the area of cardiac medicine, from cardiac patches to catheter devices, and even patient-specific heart valves models. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: ‘Evaluation of Local Tissue Reaction After the Application of a 3D Printed Novel Holdfast Device for Left Atrial Appendage Exclusion’]
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
Laser Wars: SLM Solutions Announces Order for Massive NXG XII 600E Metal 3D Printer
SLM Solutions (AM3D.DE) previously announced that it would collaborate with military research organization Concurrent Technologies Corporation (CTC) to build a large metal printer for the Air Force Research Laboratory (AFRL). The resulting...
3D Printing Webinar and Event Roundup: October 16, 2022
Because there an insane number of events and webinars for this week’s roundup, I’m going to do things a little differently in this edition. First, I’ll list all of the...
Réplique Adds a Quality Monitoring Tool to its 3D Printing Service
Replique, a BASF venture builder company, wants to make it possible for industrial firms, such as Alstom and Miele, to 3D print spare parts the world over. All the while,...
Essentium Demos High-Speed 3D Printer at US Navy’s REPTX 2022
Essentium, a Texas-based additive manufacturing (AM) services provider and original equipment manufacturer (OEM), announced that the company successfully participated in the US Navy’s REPTX 2022 exercises, which were held August...